Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 13.05.20 in Vol 6, No 2 (2020): Apr-Jun

This paper is in the following e-collection/theme issue:

Works citing "Delivering Benefits at Speed Through Real-World Repurposing of Off-Patent Drugs: The COVID-19 Pandemic as a Case in Point"

According to Crossref, the following articles are citing this article (DOI 10.2196/19199):

(note that this is only a small subset of citations)

  1. Lisi L, Lacal PM, Barbaccia ML, Graziani G. Approaching Coronavirus Disease 2019: mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2. Biochemical Pharmacology 2020;:114169
  2. Mondaini N. Phosphodiesterase Type 5 Inhibitors and COVID-19: Are They Useful In Disease Management?. The World Journal of Men's Health 2020;38(3):254